[Immunologic tolerance of anti-Abeta antibody in the sera of AD patients].
To characterize anti-amyloid-beta antibodies in the sera of Alzheimer's disease(AD) patients. A special tissue amyloid plaque immunoreactivity (TAPIR) examinations of brains of Tg2576 mice was carried out. Abeta(42)-GST fusion protein was detected by Western blot. and then the survival rate of PC12 cells incubated with the sera and Abeta(42) was measured by MTT assay. The sera in AD patients could not recognize the senile plaque in the brains of Tg2576 mice and could not cross-react with Abeta(42)-GST fusion protein. Furthermore, PC12 cells incubated with the sera from AD patients presented the decreased A value compared with the healthy elderly(P<0.01). The anti-Abeta antibodies in the sera of AD patients may have immunologic tolerance to amyloid peptide.